Antibiotic resistance, a global health concern, has been largely attributed to the irrational use of antibiotics. Therefore, promoting rational use of antibiotics is crucial in modern medicine.
Antibiotic stewardship is a coordinated strategy to improve and measure the appropriate use of antibiotics. It promotes the selection of the optimal antibiotic regimen, dose, duration of therapy, and route of administration. Stewardship efforts can significantly reduce overuse and misuse of antibiotics, thereby reducing resistance.
Firstly, antibiotics should only be prescribed when there is evidence of a bacterial infection. Secondly, the choice of antibiotic should be based on the susceptibility pattern of the causative organism. Thirdly, the dose and duration of antibiotic therapy should be appropriate for the type and site of infection. Lastly, the patient's clinical response should be monitored to assess the effectiveness of the treatment.
Diagnostic tests play a pivotal role in the rational use of antibiotics. These tests can help identify the causative organism and its antibiotic susceptibility pattern, enabling physicians to select the appropriate antibiotic. Rapid diagnostic tests can also limit the unnecessary use of broad-spectrum antibiotics while awaiting culture results.
Education of patients about the appropriate use of antibiotics is essential. Patients should be informed about the risks associated with unnecessary antibiotic use, including the development of antibiotic resistance. They should also be educated about the importance of adhering to the prescribed antibiotic regimen.
The rational use of antibiotics is a shared responsibility of healthcare providers and patients. Through antibiotic stewardship, diagnostic tests, and patient education, we can promote patient health and combat antibiotic resistance. It is essential that we continue to strive for the judicious use of antibiotics in modern medicine.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation